Reveal Pharmaceuticals
Cambridge
About Reveal Pharmaceuticals
Gadolinium-free MRI contrast agents for all patients who need crucial medical imaging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $4.9M
- Last round: Grant (May 2023)
- Website: revealpharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/reveal-pharmaceuticals-75309 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.